Home Tags XMT-1592

Tag: XMT-1592

Mersana Therapeutics and Janssen Biotech Sign Agreement to Advance Novel Antibody-Drug...

Mersana Therapeutics has signed a research collaboration and license agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to...

Phase I Dose Escalation Study with Mersana’s XMT-1592 Doses First Patient

Clinical-stage biopharmaceutical company Mersana Therapeutics has confirmed that a first patient has been dosed in a Phase I dose-escalation study evaluating XMT-1592. XMT-1592 is the...

X